GLENMARK PHARMACEUTICALS
Back to Cashflow Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-828 Cr | ₹-265 Cr | ₹625 Cr | ₹1,109 Cr | ₹1,131 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLENMARK PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-828 Cr |
| Mar2024 | ₹-265 Cr |
| Mar2023 | ₹625 Cr |
| Mar2022 | ₹1,109 Cr |
| Mar2021 | ₹1,131 Cr |
How is Cash Flow from Operating Activities of GLENMARK PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-828 Cr | Negative | |
| Mar2024 | ₹-265 Cr | Negative | |
| Mar2023 | ₹625 Cr | -43.59 | |
| Mar2022 | ₹1,109 Cr | -1.99 | |
| Mar2021 | ₹1,131 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹62,480.5 Cr | 2.7% | -6.9% | 29% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 2.7% |
-6.9% |
29% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses